| Name | Title | Contact Details |
|---|
Anrad Corporation is a Saint-Laurent, QC-based company in the Healthcare, Pharmaceuticals, & Biotech sector.
Mission Canon Medical Systems USA delivers innovative imaging solutions and services through our Made for Life philosophy to improve the quality of life for all people. Our Heritage Canon Medical Systems is born from two global leadersāCanon and Toshiba Medical. In business for more than 100 years` Toshiba Medical was built to improve the quality of life for all people. It delivered on this mission with medical innovations that are Made for Lifeāmade to improve the lives of patients` clinicians and administrators. Its legacy was built with pioneering medical technology` such as the world`s first X-ray machines in 1932 and Japan`s first Magnetic Resonance Imaging systems (MRI) in 1983. Toshiba Medical`s vision was strengthened in 2016 with its acquisition by Canon. Canon entered the healthcare business in 1940 with the development of Japan`s first indirect X-ray camera which was used for the early detection of pulmonary tuberculosis. The partnership of these two companies (now Canon Medical Systems Corporation)` brings together two cutting-edge technology businesses` founded with similar values of creativity` flexibility and patient-friendly healthcare solutions. Today` their combined history of research and innovation drive forward Canon Medical Systems` vision for building a world-class healthcare enterprise.
The Critical Path Institute is a Tucson, AZ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Founded in 2011, Sight Sciences develops and commercializes intelligently designed and engineered products that target the underlying causes of the world`s most prevalent eye diseases. The company`s surgical glaucoma product portfolio features the OMNI Surgical System, a dually indicated MIGS device that facilitates the performance of both ab interno trabeculotomy and transluminal viscoelastic delivery. Using proprietary multi-modal functionality, OMNI allows surgeons to target all three sources of resistance in the conventional outflow pathway (trabecular meshwork, Schlemm`s canal and collector channels) with a single device and single corneal incision. The company`s non-surgical dry eye product portfolio consists of the TearCare for ophthalmologists and optometrists. TearCare is a software-controlled, wearable, therapeutic eyelid technology designed to melt and clear obstructions of the meibomian glands within the eyelids. Leveraging the full functionality of the blinking eye, proprietary SmartLid⢠technology is designed to conform to all eyelid anatomies and achieve therapeutic meibum melting temperatures at the tarsal conjunctiva thereby clearing meibomian gland obstructions while sparing the cornea. Improved meibum production results in a higher quality lipid layer and higher quality tears.
CHF Solutions is an early stage company focused on commercializing the Aquadex FlexFlow system. Our objective is to improve the quality of life for patients with heart failure and related conditions, such as fluid overload. At CHF Solutions, we are committed to the relentless pursuit of identifying and developing innovative solutions to address unmet clinical needs with the goal of benefiting patients, medical practitioners, and the broader healthcare community.